Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04934020 · ClinicalTrials.gov registry record
Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 345,089
- Enrollment target
NCT04934020 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 345,089 participants.
The verdict
NCT04934020 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 345,089 participants
- Enrollment target
Study Summary
A 1-year analysis of global selected stroke metric data will be conducted comparing the results during the Covid-19 pandemic to the pre-pandemic period. In most countries, this will correspond to March 1, 2020 to February 28, 2021. In some countries, the pandemic period would be adjusted for onset of case surge (i.e. China pandemic start date would begin earlier, i.e. January 2020). The specific metrics that will be analyzed include: 1. ischemic stroke or transient ischemic attacks (TIA) hospitalizations 2. intracranial hemorrhage hospitalizations 3. cerebral venous thrombosis (CVT) hospitalizations (with or without thrombocytopenia) 4. CVT in-hospital mortality 4\) aneurysmal subarachnoid hemorrhage hospitalizations 5) mechanical thrombectomy 6) intravenous thrombolysis 7) ruptured aneurysm endovascular coiling 8) ruptured aneurysm clipping. 9) aneurysmal subarachnoid hemorrhage admissions 10) SAH in-hospital mortality 11) SAH presentation by Hunt Hess Grade
Interventions
- OTHER Pre-pandemic stroke related metrics
- OTHER Stroke related metrics during the pandemic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 345,089 participants |
| Start Date | 2021-04-25 |
| Est. Completion | 2021-12-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04934020
The ClinicalTrials.gov registry entry for NCT04934020 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 345,089 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pre-pandemic stroke related metrics is the first listed.
NCT04934020 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04934020 about?
NCT04934020 is a clinical study titled "Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage". A 1-year analysis of global selected stroke metric data will be conducted comparing the results during the Covid-19 pandemic to the pre-pandemic period. In most countries, this will correspond to March 1, 2020 to February 28, 2021. In some countries, the pandemic period would be adjusted for onset o...
What is the current status of trial NCT04934020?
This trial is currently completed. The enrollment target is 345,089 participants. The study started on 2021-04-25. Estimated completion is 2021-12-09.
What interventions are being tested in trial NCT04934020?
The interventions under investigation include: Pre-pandemic stroke related metrics (OTHER), Stroke related metrics during the pandemic (OTHER).
Who is sponsoring clinical trial NCT04934020?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.